UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

: Levaxin-200mg-Tablet-SE-BS-RA - JSON Representation

Raw json | Download


{
  "resourceType" : "RegulatedAuthorization",
  "id" : "Levaxin-200mg-Tablet-SE-BS-RA",
  "meta" : {
    "profile" : [
      🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"
    ]
  },
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization Levaxin-200mg-Tablet-SE-BS-RA</b></p><a name=\"Levaxin-200mg-Tablet-SE-BS-RA\"> </a><a name=\"hcLevaxin-200mg-Tablet-SE-BS-RA\"> </a><a name=\"hcLevaxin-200mg-Tablet-SE-BS-RA-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/21055</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-Levaxin-200mg-Tablet-SE-BS-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-XXXXXXXXX-00021055,http://ema.europa.eu/fhir/eurdId#1860; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Hypotyreos av alla former t ex vid autoimmun tyreoidit, efter radiojod- och kirurgisk terapi av hypertyreos och vid progressiv oftalmopati när den är förenad med hypotyreos.  Som tillägg till tyreostatika vid långtidsbehandling av hypertyreos och vid preoperativ kombinationsbehandling av hypertyreos. Tyreoideacancer. Myxödemkoma.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = levothyroxine sodium</a></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}\">Valid</span></p><p><b>statusDate</b>: 2005-09-16</p><p><b>holder</b>: <a href=\"Organization-LOC-XXXXXXXXX.html\">Organization Orifarm Healthcare A/S</a></p><h3>Cases</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}\">First Authorisation</span></td><td>2005-09-16</td></tr></table></div>"
  },
  "identifier" : [
    {
      "system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
      "value" : "21055"
    }
  ],
  "subject" : [
    {
      🔗 "reference" : "MedicinalProductDefinition/Levaxin-200mg-Tablet-SE-BS-MPD"
    }
  ],
  "type" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/v1/lists/220000000060",
        "code" : "220000000061",
        "display" : "Marketing Authorisation"
      }
    ]
  },
  "region" : [
    {
      "coding" : [
        {
          "system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
          "code" : "100000000535",
          "display" : "Kingdom of Sweden"
        }
      ]
    }
  ],
  "status" : {
    "coding" : [
      {
        "system" : "https://spor.ema.europa.eu/v1/lists/100000072049",
        "code" : "100000072099",
        "display" : "Valid"
      }
    ]
  },
  "statusDate" : "2005-09-16",
  "holder" : {
    🔗 "reference" : "Organization/LOC-XXXXXXXXX"
  },
  "case" : {
    "type" : {
      "coding" : [
        {
          "system" : "https://ema.europa.eu/fhir/authorisationDateType",
          "code" : "dateOfFirstAuthorisation",
          "display" : "First Authorisation"
        }
      ]
    },
    "dateDateTime" : "2005-09-16"
  }
}